<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>HYPOTHESIS: <z:chebi fb="0" ids="3098">Bile acid</z:chebi> exposure can induce caudal-related homeobox 2 (CDX2) <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) expression, a transcription factor that plays a crucial role in the development of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated mucin 2 (MUC2) and CDX2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression before and after treatment with <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> in 4 human esophageal cell lines </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN, SETTING, AND PARTICIPANTS: Four human esophageal cell lines-(1) <z:mpath ids='MPATH_458'>normal</z:mpath> squamous cells immortalized by SV40 (Het-1A), (2) <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (SEG-1), and (3 and 4) <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> (HKESC-1 and HKESC-2)-were exposed in culture for 1 to 24 hours to 100 microM to 1000 microM <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Total <z:chebi fb="40" ids="33697">RNA</z:chebi> was extracted before and after <z:chebi fb="0" ids="3098">bile acid</z:chebi> treatment and reverse transcribed to complementary DNA </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURE: MUC2 and CDX2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression as determined by semiquantitative reverse transcription-polymerase chain reaction </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: MUC2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was absent before <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> exposure in <z:hpo ids='HP_0000001'>all</z:hpo> 4 cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>MUC2 expression increased in a dose- and time-dependent manner with <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> in <z:hpo ids='HP_0000001'>all</z:hpo> cell lines </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="28834">Deoxycholic acid</z:chebi> activated MUC2 up-regulation, which correlated directly with CDX2 up-regulation in <z:hpo ids='HP_0000001'>all</z:hpo> 4 cell lines </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:chebi fb="1" ids="3098">Bile acids</z:chebi> up-regulate both intestinal differentiation factor CDX2 and goblet cell-specific gene MUC2 in <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines </plain></SENT>
<SENT sid="9" pm="."><plain>Further, <z:chebi fb="0" ids="3098">bile acid</z:chebi>-stimulated MUC2 up-regulation correlates directly with CDX2 up-regulation </plain></SENT>
<SENT sid="10" pm="."><plain>The simultaneous up-regulation of both CDX2 and MUC2 after <z:chebi fb="0" ids="3098">bile acid</z:chebi> exposure provides molecular evidence of the role of <z:chebi fb="0" ids="3098">bile acid</z:chebi> in the pathogenesis of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
</text></document>